Cortical Penetration
Cortical Penetration - Related Videos
10:12
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
0 Views •
Cited by 5 •
2022
This protocol describes the synthesis of cyclic cell-penetrating peptides with aromatic cross-links and the evaluation of their permeability across biological barriers.
08:39
Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
0 Views •
Cited by 6 •
2017
The goal of this protocol is to alter the penetrance of lethal skeletal mutant phenotypes in zebrafish by selective breeding. Lethal mutants cannot be grown to adulthood and bred themselves, therefore this protocol describes a method for tracking and selecting penetrance through multiple generations by progeny testing.
03:30
Inducing Penetrating Traumatic Brain Injury in Adult Drosophila Flies
0 Views •
2025
This video demonstrates the induction of penetrating traumatic brain injury in the drosophila brain. Newly emerged flies are selected, anesthetized, and positioned under a fluorescence-equipped stereo microscope. The GFP-expressing mushroom body is identified, and a Minutien pin is inserted to cause injury. The flies are allowed to recover for further studies.
06:42
Subtype-selective Electroporation of Cortical Interneurons
0 Views •
Cited by 13 •
2014
This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.
02:58
Fluorescence Leakage Assay to Study Cell-Penetrating Peptide Interaction with Membrane
0 Views •
2025
This video discusses the fluorescence leakage assay to study the interactions of cell-penetrating peptides with cell membranes using cell membrane mimics — large unilamellar vesicles, or LUVs, encapsulated with a fluorescent dye and a quencher.
FAQs
The blood-brain barrier can restrict the movement of therapeutic substances from the circulation into brain tissue. Its limiting effect interacts with a compound’s molecular size and other properties, so two substances delivered under similar conditions may reach the cortex differently. Evaluating this barrier is therefore essential when assessing whether a medicine can achieve useful exposure in cortical regions.
Molecular size and other molecular properties influence how readily a therapeutic substance crosses the blood-brain barrier and moves through cortical tissue. These characteristics help determine both initial access and subsequent distribution after entry. Considering them during medicine development can clarify why a formulation produces limited cortical exposure or spreads more effectively across the targeted tissue.
Blood flow helps determine how much therapeutic substance is delivered to brain regions, while tissue diffusion influences how far it spreads after reaching those regions. Their combined effects can produce differences in cortical exposure even when the same substance is used. These variables are important for interpreting distribution and for refining delivery strategies in neurological research.
The delivery route affects the conditions under which a therapeutic substance encounters the blood-brain barrier and reaches cortical tissue. Route selection therefore becomes part of the strategy for improving access and distribution, rather than a separate logistical decision. Comparing routes can support targeted delivery approaches when conventional exposure does not provide adequate penetration into the cortex.
Measurement provides evidence about how effectively a therapeutic substance reaches and distributes through cortical regions. Researchers can use that information to evaluate whether a candidate medicine or formulation is likely to address disease-affected brain tissue. The results also support decisions about dosing strategies and targeted delivery during the development of treatments for neurological disorders.
Cortical penetration is particularly relevant when disease affects brain tissue, including brain tumors, epilepsy, stroke, and neuroinflammatory disease. In these settings, understanding access to cortical regions helps researchers evaluate therapeutic delivery in relation to the affected tissue. The findings can inform medicine development, formulation choices, dosing strategies, and targeted delivery approaches.